Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback